Gen-Probe Relying On Tigris To Boost Overseas Blood Screen Market Share
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe projects a U.S. market launch in the first half of 2004 for its Tigris DTS fully automated, high-throughput molecular diagnostic instrument system